Zichen Cao Selected Research

Zichen Cao Research Topics

4	Neoplasms (Cancer) 01/2023 - 01/2021
3	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2023
1	Hyperthermia 01/2023
1	Hemorrhage 10/2022
1	Cerebral Hemorrhage 10/2022
1	Thromboembolism 10/2022
1	Thrombosis (Thrombus) 10/2022
1	Photophobia (Light Sensitivity) 03/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Parkinson Disease (Parkinson's Disease) 11/2019
1	Brain Ischemia (Cerebral Ischemia) 11/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2019

2	Photosensitizing Agents (Photosensitizers)IBA 01/2023 - 03/2022
1	Terbinafine (Lamisil)FDA LinkGeneric 01/2023
1	CholesterolIBA 01/2023
1	Lysine (L-Lysine)FDA Link 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	FibrinIBA 10/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 10/2022
1	glycyl-prolyl-arginyl-prolineIBA 10/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 10/2022
1	ParaffinIBA 10/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2022
1	Peptides (Polypeptides)IBA 10/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022
1	ProdrugsIBA 01/2021
1	Tirapazamine (SR 4233)IBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Therapeutic UsesIBA 01/2021
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 11/2019
1	Neuroprotective AgentsIBA 11/2019

2	Photothermal Therapy 01/2023 - 01/2021
2	Therapeutics 10/2022 - 01/2021
2	Photochemotherapy (Photodynamic Therapy) 03/2022 - 01/2021
2	Phototherapy (Light Therapy) 01/2021 - 01/2021
1	Radiotherapy 01/2023
1	Immunotherapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2021